OM1 Doubles Lupus Dataset, Representing 56,000+ Patients Prospectively Followed With Deep Clinical Data
OM1, a leading real-world data, outcomes and technology company with a focus on chronic conditions, today announced the expansion of its lupus dataset, PremiOM™ SLE.
› READ THE RELEASEPOSTERS
Real-World Characterization and Management of Alopecia Areata Patients in the U.S.
MAY 16, 2023
View our poster on Real-World Characterization and Management of Alopecia Areata Patients in the U.S. Click to view!
Machine Learning Models to Estimate Disease Activity Measures in RealWorld Data Sources: Lessons Learned from Four Autoimmune Diseases
MAY 16, 2023
View our poster on Machine Learning Models to Estimate Disease Activity Measures in RealWorld Data Sources: Lessons Learned from Four Autoimmune Diseases. Click to view!
EVENTS
American Psychiatric Association Annual Meeting
MAY 16, 2023
When: May 20-24 Where: Moscone Center, San Fransisco, CA Booth Location: 1135 Events On Site: Panel Presentation Treatment Resistant Depression from Multiple Perspectives: Does It Exist? In partnership with Compass Pathways Saturday, May 20 1:30 pm – 3:00 pm Room 303 Moscone South Poster Presentation Use of Medical Language Processing in Real-World Data to Understand[…]
ISPOR Annual Meeting
MAY 16, 2023
When: May 6-10 Where: Boston Convention and Exhibit Center, Boston, MA Booth Location: 716 Events On Site: Poster Presentations Real-World Characterization and Management of Alopecia Areata Patients in the U.S. Monday, May 8, 2023 Poster Session 2 Poster Code: RWD62 Poster session time: 3:15 PM – 6:45 PM Presentation time: 5:45 PM – 6:45 PM[…]
EBOOKS
Real-World Analysis & Insights from the OM1 Neuroscience Specialty Network
NOV 27, 2023
OM1 is reimagining real-world evidence with the development of large, electronically connected networks of clinicians in key specialty areas. This ebook explores powerful insights, analyses, and use cases that leverage AI and data science from OM1’s Neuroscience Specialty Network. View ebook >>
Analyses & Insights from the OM1 Lupus Data Network Ebook
MAY 16, 2023
At OM1, we use RWD to create digital data networks to answer research questions and improve patient outcomes. In this E-Book you will find a sampling of: Market trends Data on Lupus Subtypes Artificial Intelligence Applications Case studies And more! Download>> *Due to proprietary information contained in our materials, we do not currently distribute them[…]
VIDEOS
Multiple Sclerosis eEDSS – Data Science Point of View
APR 13, 2023
Costas Boussios, Chief Data Scientist, OM1 details estimated EDSS score for Multiple Sclerosis were developed.
NEWS & ARTICLES
How AI Can Help Dermatology: Diagnosis, Treatment, Risk, and R&D
NOV 15, 2023
HealthEconomics.com November 15, 2023 Listen to the full podcast >> The hype around AI is finally translating into real-world value, and we are seeing broader adoption of real-world data in Dermatology. This episode of tHEORetically Speaking features Dr. Stefan Weiss, Managing Director of Dermatology and Dr. Joseph Zabinski, Managing Director of AI and Personalized Medicine[…]
Meet Your 40 Under 40 Winner – Joseph Zabinski, PhD, MEM Managing Director of AI & Personalized Medicine, OM1
NOV 15, 2023
Healthcare Innovation September 19, 2023 Read the full article >> Congratulations to 40 Under 40 Winner: Joseph Zabinski, PhD, MEM, Managing Director of AI & Personalized Medicine, OM1 Get To Know Joseph: Age (as of December 31, 2023): 35 Hometown: Cortlandt Manor, NY Alma Mater: Boston College (BS), Dartmouth (MEM), UNC (PhD) Number of Years of Experience in Healthcare: 8[…]
WHITE PAPERS
From Big Data to Measurable Outcomes: OBC
JUL 6, 2017
A heightened focus on value is driving efforts across health care to improve outcomes and reduce costs. For pharmaceutical companies, this focus translates into a shift away from traditional payment models to more outcomes-based, risk sharing agreements. In many ways, these agreements present the opportunity to better align interests across health care’s stakeholders. However, they[…]
Improving Performance under Bundled Care
NOV 5, 2016
The field of medicine is changing rapidly due to two major disruptions – the application of artificial intelligence, such as machine and deep learning and the shift from fee-for-service to value-based payment models. These innovations, which are occurring simultaneously, are fundamentally altering how data are used and how care is provided. To survive in this[…]
WEBINARS
Shifting the Paradigm (and Prince)on Integrated Evidence Generation
SEP 18, 2023
MAPS Webinar 9/15/23 Listen tot he full webianr >> Clinical research is typically costly for sponsors and burdensome for providers and patients. New methods and approaches, such as integrated evidence generation using real-world data networks and automated study platforms, are accelerating the path from start-up to read out.
Improving Patient Outcomes: AI-Based Phenotyping for Diagnosis, Treatment, and Clinical Trials
JUN 7, 2023
Register to watch>> Join a panel of OM1’s clinical experts in cardiometabolic disease, immunology, and mental health as they explore how Artificial Intelligence (AI) can find phenotypic patterns and unlock insights hidden in real-world data. Extracting as much information as possible from real-world datasets is essential for understanding the complete patient journey. Subtle patterns in[…]